Age-specific predictors of cervical dysplasia recurrence after primary conization: analysis of 3,212 women.
Adult
Age Factors
Conization
Female
Human papillomavirus 16
Human papillomavirus 18
Humans
Middle Aged
Neoplasm Recurrence, Local
/ pathology
Papillomaviridae
Papillomavirus Infections
/ pathology
Prospective Studies
Retrospective Studies
Uterine Cervical Neoplasms
/ pathology
Uterine Cervical Dysplasia
/ pathology
Conization
Human Papillomavirus 16
Papillomavirus Infections
Squamous Intraepithelial Lesions of the Cervix
Journal
Journal of gynecologic oncology
ISSN: 2005-0399
Titre abrégé: J Gynecol Oncol
Pays: Korea (South)
ID NLM: 101483150
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
30
12
2019
revised:
31
03
2020
accepted:
06
04
2020
entrez:
19
8
2020
pubmed:
19
8
2020
medline:
2
9
2021
Statut:
ppublish
Résumé
This study aimed to identify predictors of recurrence/persistence of cervical intraepithelial neoplasia grade 2+ (CIN2+) lesion (r-CIN2+) after primary conization. Retrospective analysis involving all consecutive women having conization for CIN2+ between 1998 and 2018. The risk of r-CIN2+ was assessed using Kaplan-Meier and Cox models. Data of 3,212 women were retrospectively identified. After a mean follow-up of 47 (±22.2) months, 112 (3.5%) patients developed r-CIN2+. Mean time interval between prior conization and diagnosis of r-CIN2+ was 26.2 (±13.2) months. Via multivariate analysis, presence of high-risk human papillomavirus (HPV) types at the time of CIN2+ diagnosis, hazard ratio (HR)=3.40 (95% confidence interval [CI]=1.66-6.95) for HPV16/18 and HR=2.59 (95% CI=1.21-5.55) for HPV types other than 16/18, positive margins at primary conization, HR=4.11 (95% CI=2.04-8.26) and HPV persistence after conization, HR=16.69 (95% CI=8.20-33.9), correlated with r-CIN2+, independently. Considering age-specific HPV types distribution, we observed that HPV16/18 infection correlated to an increased risk of r-CIN2+ only in young women (aged ≤25 years; p=0.031, log-rank test); while in the older population (>25 years) HPV type(s) involved had not impact on r-CIN2+ risk (p>0.200, log-rank test). HPV persistence is the main factor predicting r-CIN2+. Infection from HPV16/18 has a detrimental effect in young women, thus highlighting the need of implementing vaccination against HPV in this population. Further prospective studies are warranted for tailoring clinical decision-making for post-conization follow-up on the basis of risk factors.
Identifiants
pubmed: 32808492
pii: 31.e60
doi: 10.3802/jgo.2020.31.e60
pmc: PMC7440983
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e60Informations de copyright
Copyright © 2020. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology.
Déclaration de conflit d'intérêts
No potential conflict of interest relevant to this article was reported.
Références
Gynecol Oncol. 2019 Aug;154(2):345-353
pubmed: 31242966
Lancet Public Health. 2016 Nov;1(1):e8-e17
pubmed: 29253379
Eur J Cancer Prev. 2019 Mar;28(2):81-86
pubmed: 29360648
Gynecol Oncol. 2008 Mar;108(3):549-54
pubmed: 18177929
Gynecol Oncol. 2019 Aug;154(2):354-359
pubmed: 31176553
Eur J Cancer Prev. 2019 Sep;28(5):435-440
pubmed: 30489353
Lancet. 2019 Jan 12;393(10167):169-182
pubmed: 30638582
Eur J Cancer. 2020 Mar;127:207-223
pubmed: 31980322
PLoS One. 2015 Dec 01;10(12):e0142868
pubmed: 26624896
Lancet Oncol. 2019 Feb;20(2):229-238
pubmed: 30658933
Eur J Obstet Gynecol Reprod Biol. 2012 Nov;165(1):86-90
pubmed: 22771223
Lancet Oncol. 2017 Dec;18(12):1665-1679
pubmed: 29126708
Gynecol Oncol. 2018 Nov;151(2):229-234
pubmed: 30197061
Lancet. 2019 Aug 10;394(10197):497-509
pubmed: 31255301